logo
  

Enveric Biosciences Names Carter Ward CFO - Quick Facts

Enveric Biosciences (ENVB) has appointed Carter Ward as CFO, effective May 15th, 2021. He is replacing John Van Buiten. Prior to joining the company, Ward most recently served as CFO at Elite Pharmaceuticals. John Van Buiten is expected to remain in a consulting role with the company.

"Since becoming a public company in late-December 2020, Enveric has already achieved notable strategic milestones, working diligently to execute its vision of bringing new-generation, naturally occurring and synthetic compounds to cancer patients who need better, safer supportive care treatments," said Ward.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Shares of Apple Inc. (AAPL) jumped nearly 5% in extended trading session on Thursday after the California-based tech giant reported first-quarter results, with both earnings and revenues trumping Wall Street's expectations, driven by strong demand for its latest iPhone 13 and other services. Apple... The U.S. Food and Drug Administration has revised the authorizations for two monoclonal antibody treatments - bamlanivimab and etesevimab (administered together) and REGEN-COV (casirivimab and imdevimab) - to limit their use to only when the patient is likely to have been infected with or exposed to a variant that is susceptible to these treatments. Comcast Corp. (CMCSA, CMCSK) on Thursday reported that net income attributable to Comcast for the quarter decreased 9.6 percent to $3.06 billion or $0.66 per share from $3.38 billion or $0.73 per share in the year-ago quarter. Excluding items, adjusted earnings for the quarter were $0.77, compared to...
RELATED NEWS
Follow RTT